Researchers have taken a promising step forward in using stem cells to treat eye diseases. In a paper published today online in the journal Cloning and Stem Cells, Robert Lanza of Advanced Cell Technology in Worcester, MA, used embryonic stem cells to generate retinal pigment epithelium–photoreceptor support cells that are lost in macular degeneration.
The cells were then implanted into rats with eye damage similar to that occurring in degenerative eye disease that causes the animals to lose both their photoreceptors and their sight. Treated animals showed a 100 percent improvement in vision compared with untreated controls.
Restoring vision could be a promising early use of stem cell therapies. Unlike for diseases such as Alzheimer’s, vision scientists know exactly what cells they need to replace. In addition, the eye is easy to access and isn’t as sensitive to immune rejection as other organs (see “Using Stem Cells to Cure Blindness”).
Forget dating apps: Here’s how the net’s newest matchmakers help you find love
Fed up with apps, people looking for romance are finding inspiration on Twitter, TikTok—and even email newsletters.
How AI is reinventing what computers are
Three key ways artificial intelligence is changing what it means to compute.
These weird virtual creatures evolve their bodies to solve problems
They show how intelligence and body plans are closely linked—and could unlock AI for robots.
We reviewed three at-home covid tests. The results were mixed.
Over-the-counter coronavirus tests are finally available in the US. Some are more accurate and easier to use than others.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.